Scribe Therapeutics Shares Rise in Nasdaq Debut

MT Newswires Live

3小時前

Scribe Therapeutics (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.

The stock opened at $25 and was up over 50% at around $22.61 after midday.

The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.

It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.

Price: 22.61, Change: +7.61, Percent Change: +50.75

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2654039861"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2654039861\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2654039861?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-25 00:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2654039861","market":"us","top_or_hot":-1,"title":"Scribe Therapeutics Shares Rise in Nasdaq Debut","media":"MT Newswires Live","content":"<html><body><p> Scribe <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.</p><p>The stock opened at $25 and was up over 50% at around $22.61 after midday.</p><p>The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.</p><p>It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and <a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> Securities are joint book-running managers for the offering.</p><p>Price: 22.61, Change: +7.61, Percent Change: +50.75</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Scribe Therapeutics Shares Rise in Nasdaq Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nScribe Therapeutics Shares Rise in Nasdaq Debut\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-07-25 00:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Scribe <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.</p><p>The stock opened at $25 and was up over 50% at around $22.61 after midday.</p><p>The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.</p><p>It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and <a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> Securities are joint book-running managers for the offering.</p><p>Price: 22.61, Change: +7.61, Percent Change: +50.75</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SCTX","symbol_name":"Scribe Therapeutics, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2654039861","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2654039861","pubTimestamp":1784912164,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Scribe Therapeutics  shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.The stock opened at $25 and was up over 50% at around $22.61 after midday.The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.Price: 22.61, Change: +7.61, Percent Change: +50.75","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SCTX":"Scribe Therapeutics, Inc.","LCLG":"Logan Capital Broad Innovative Growth ETF"},"translate_title":"Scribe Therapeutics 股价在纳斯达克首次亮相时上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SCTX":1.5,"LCLG":1.5,"NQmain":1.5},"content_text":"Scribe Therapeutics (SCTX) shares were up sharply in their Friday debut on Nasdaq after the company priced its initial public offering of 8.58 million shares at $15.00 per share.The stock opened at $25 and was up over 50% at around $22.61 after midday.The clinical-stage biotechnology company has upsized its IPO after pricing the shares at the high end of its indicative range.It has granted its underwriters a 30-day option to purchase up to almost 1.3 million additional shares. Leerink Partners, Goldman Sachs, Guggenheim Securities and Wells Fargo Securities are joint book-running managers for the offering.Price: 22.61, Change: +7.61, Percent Change: +50.75","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}